RecruitingNot ApplicableNCT06128304

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services


Sponsor

University of California, San Diego

Enrollment

2,436 participants

Start Date

Nov 13, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.


Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 64 Years

Inclusion Criteria1

  • Women living with HIV

Exclusion Criteria1

  • \-

Interventions

OTHERCore Implementation strategies

Core Implementation Strategies 1. Ongoing consultation 2. Educational meetings 3. Strengthen referral system 4. Prepare patients to be active participants

OTHERCore+ Enhanced Implementation Strategies

Includes all of the Core implementation strategies and adds: 5\. Community engagement using Health Beginning Initiative Model 6\. Smart Cards to facilitate patient engagement


Locations(2)

UC San Diego

La Jolla, California, United States

University of Nigeria, Nsukka

Enugu, Enugu State, Nigeria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06128304


Related Trials